Details of the Drug Reposition

General Information of This Drug (ID: DMRYH3M)

Drug Name
ADP-A2M4   DMRYH3M

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Synovial sarcoma DISEZJS7 2B5A Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of Adaptimmune.
2 Clinical pipeline report, company report or official report of Adaptimmune.